Dosing Recommendations for Concomitant Medications During 3D Anti-HCV Therapy

Clinical Pharmacokinetics- United Kingdom

doi 10.1007/s40262-015-0317-8

Full Text

Abstract

Available in

Categories

Pharmacology

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Real-World Dosing of Evidence-Based Medications for Heart Failure: Embracing Guideline Recommendations and Clinical Judgement

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

ASSOCIATION BEETWEEN IL-28β POLYMORPHISMS AND EFFECTIVENESS OF CONCOMITANT THERAPY OF HIV INFECTION IN PATIENTS WITH HCV/HIV CO-INFECTION DURING THE ANTIVIRAL THERAPY

Russian Journal of Infection and Immunity
Infectious DiseasesAllergyImmunology
2014English

Skin Adverse Events During Dual and Triple Therapy for HCV-Related Cirrhosis

Hepatitis Monthly
HepatologyInfectious Diseases
2014English

Change of Anti-HCV Antibody Titer During Interferon Therapy. Investigation of NS3, NS4 and Core Region Antibody.

Acta Hepatologica Japonica
Hepatology
1993English

Concomitant Medications and Risk of Chemotherapy‐Induced Peripheral Neuropathy

Oncologist
Cancer ResearchMedicineOncology
2018English

Beta-Lactam Antibiotic Dosing During Continuous Renal Replacement Therapy: How Can We Optimize Therapy?

Critical Care
Critical CareIntensive Care Medicine
2014English

Cellular Immune Responses to HCV Core Increase and HCV RNA Levels Decrease During Successful Antiretroviral Therapy

Gut
Gastroenterology
2010English

Anesthetic Considerations for the New Anti-Obesity Medications

The Internet Journal of Anesthesiology
1997English

Drug Dosing During Hypothermia

Pediatric Critical Care Medicine
Child HealthCritical CarePediatricsPerinatologyIntensive Care Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy